Effect of Combining a Posterosuperior Humeral Notch Filling With a Coracoid Bone Block on the Rate of Return to Sport
Condition(s) studied
Investigational drug(s) / intervention(s)
Filling of the posterior superior notch of the humerus: The intervention involves bringing part of the coracoid bone with the tendon attached to it onto the front of the glenoid cavity. The stop is secured with an endobutton. The additional procedure used in this study is filling the posterosuperior notch of the humerus. The filling technique involves placing two anchors, which causes tenodesis of the infraspinatus in the posterosuperior notch of the humerus.
Study summary
The goal of this interventional study is to demonstrate the benefit of combining filling of the posterosuperior notch of the humerus with a coracoid stop on the rate of return to sports at the same level as before at 12 months post-surgery.
The level of sport will be categorized as recreational, competitive, or professional.
This is a prospective, single-center, comparative study of two parallel randomized groups, using a single-blind design.
The patients included will be randomized into two groups with a 1:1 ratio: one group will undergo the filling technique, while the second group will not. The rest of the surgery will be similar.
Randomization will be stratified according to initial athletic level.
Eligibility
Primary outcome measure(s)
- Number of Participants returning to sports at the same level after surgery, in each arms, at 12months — 12 months
Difference between the two arms for returning to sports at the same level as before, categorized into three levels: recreational, competitive, or professional, 12 months after surgery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinique St Jean Sud de France | Saint-Jean-de-Védas | France |
More Clinique Saint Jean, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07257081 on ClinicalTrials.gov ↗ ← All trials in France